Don’t Be Fooled Again
by Bill Wilson, KIN Senior Analyst
December 10, 2025
WASH—Dec 10—KIN–Pfizer is back in the spotlight, rolling out trial results that claim its new mRNA influenza vaccine outperforms the standard flu shot. The headlines trumpet “better efficacy,” as if we’ve all forgotten the last three years. But FDA Commissioner Dr. Marty Makary says it’s a non-starter, “The trial showed zero benefit” for seniors.” Approval denied. Pfizer rolled out a press release highlighting very carefully framed numbers. They say this new shot reduced flu cases more than the conventional vaccine. What they don’t discuss with the same enthusiasm is that they’re using the exact same COVID-19 mRNA platform that triggered adverse-event warnings that are still being debated today. Who would believe a word they say? Not the new FDA.
We learned a lot during COVID, and most of it didn’t come from official talking points. Pfizer’s own early submissions showed declining protection within months and a spike in myocarditis and pericarditis—especially in young males. People who never had cardiac issues before suddenly found themselves navigating symptoms they didn’t expect. Even the FDA eventually added warnings to the label. And yet here we are again, being told that the same mRNA delivery system has now produced a superior flu shot. They want you to focus on the percentage improvements, not the risks. They want you to forget that “safe and effective” turned into “waning efficacy and unforeseen complications.” They want you to act like none of it happened. But facts are stubborn things, and memories—especially painful ones—tend to stick.
Pfizer insists side effects from this new flu shot are “consistent” with its prior mRNA vaccines. That alone should set off alarms. Consistent with what? The platform associated with heart inflammation, blood clots, miscarriages, infertility? The protection that collapses over time? The trial data that treated serious adverse events as unfortunate footnotes? Americans aren’t anti-science. They’re anti-being-sold-something-twice. After COVID, who in their right mind takes Pfizer’s self-reported success at face value? If the company wants credibility, it should lead with long-term safety data, transparent adverse-event reporting, and real-world durability. What we’re getting instead is selective storytelling wrapped in marketing optimism, hoping you don’t notice the fine print repeating itself. Hats off to the FDA for not buying it this time.
This is exactly how these drug companies bamboozle people into really bad health decisions with irreputable side effects.
We all need discernment. You don’t have to be a scientist to apply common sense. If a company’s last blockbuster vaccine came with unresolved questions, diminishing returns, and documented risks, then any product built on that same blueprint deserves serious scrutiny. The moral here is simple: don’t let déjà vu turn into deception. Ephesians 5:6 first says, “Let no one deceive you with empty words.” Pfizer may believe the public has a short memory, but a whole lot of people are living with reminders that say otherwise. Demand honesty. Demand full data. Demand accountability from corporations that expect blind trust after earning the opposite because being fooled again is, say it with me…Stupidocrisy.
Sources
Pfizer mRNA flu shot failed FDA tests for Seniors – Epoch Times
Pfizer mRNA Influenza Phase 3 Efficacy Report – Contagion Live
Pfizer Press Release on mRNA Influenza Vaccine – Pfizer
FDA Safety Communication – Myocarditis/Pericarditis for mRNA COVID-19 Vaccines – FDA
Pfizer–BioNTech Original COVID-19 Vaccine Trial Publication (efficacy data) – PMC.NCBI
Christian Conservative Coalition 